• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[多克隆断裂探针在Xp11.2易位性肾细胞癌诊断中的应用]

[Application of polyclonal break-apart probes in the diagnosis of Xp11.2 translocation renal cell carcinoma].

作者信息

Chen Xiancheng, Gan Weidong, Ye Qing, Yang Jun, Guo Hongqian, Li Dongmei

机构信息

Department of Urology, Affiliated Drum Tower Hospital, College of Medicine, Nanjing University, Nanjing 210008, China.

Email:

出版信息

Zhonghua Yi Xue Za Zhi. 2014 Dec 16;94(46):3675-7.

PMID:25622964
Abstract

OBJECTIVE

To explore the value of self-designed fluorescent in situ hybridization (FISH) polyclonal break-apart probes specific for TFE3 gene in the diagnosis of Xp11.2 translocation renal cell carcinoma.

METHODS

All tissue samples were collected from 2006 to 2013, including Xp11.2 translocation renal cell carcinoma (n = 10), renal clear cell carcinoma (n = 10) and renal papillary cell carcinoma (n = 10). FISH was conducted for paraffin-embedded tumor tissue sections with probes. The types of fluorescence were observed by fluorescent microscopy to determine the existence or non-existence of translocated TFE3 gene.

RESULTS

All sections were successfully probed. The split red and green signals within a single nucleus were detected simultaneously in 9 cases of Xp11.2 translocation renal cell carcinoma as diagnosed by traditional pathological and immunohistochemical methods. And it was consistent with the initial diagnosis. Detection of fusion signal in 1/10 and negative FISH result did not conform to the initial diagnosis. The fluorescent types of renal clear cell carcinoma and renal papillary cell carcinoma were all fusion signals. FISH tests were negative for renal clear and papillary cell carcinomas.

CONCLUSIONS

Xp11.2 translocation renal cell carcinomas diagnosed by traditional pathological and immunohistochemical methods are sometimes misdiagnosed. Detecting the translocation of TFE3 gene with FISH polyclonal break-apart probes is both accurate and reliable for diagnosing Xp11.2 translocation renal cell carcinoma.

摘要

目的

探讨自行设计的针对TFE3基因的荧光原位杂交(FISH)多克隆分裂探针在Xp11.2易位性肾细胞癌诊断中的价值。

方法

收集2006年至2013年的所有组织样本,包括Xp11.2易位性肾细胞癌(n = 10)、肾透明细胞癌(n = 10)和肾乳头状细胞癌(n = 10)。用探针进行石蜡包埋肿瘤组织切片的FISH检测。通过荧光显微镜观察荧光类型,以确定是否存在易位的TFE3基因。

结果

所有切片均成功进行探针检测。在9例经传统病理和免疫组化方法诊断为Xp11.2易位性肾细胞癌的病例中,同时检测到单个细胞核内的红色和绿色分裂信号,且与初步诊断一致。1/10的病例检测到融合信号,FISH阴性结果与初步诊断不符。肾透明细胞癌和肾乳头状细胞癌的荧光类型均为融合信号,肾透明细胞癌和乳头状细胞癌的FISH检测均为阴性。

结论

经传统病理和免疫组化方法诊断的Xp11.2易位性肾细胞癌有时会被误诊。用FISH多克隆分裂探针检测TFE3基因易位对诊断Xp11.2易位性肾细胞癌准确可靠。

相似文献

1
[Application of polyclonal break-apart probes in the diagnosis of Xp11.2 translocation renal cell carcinoma].[多克隆断裂探针在Xp11.2易位性肾细胞癌诊断中的应用]
Zhonghua Yi Xue Za Zhi. 2014 Dec 16;94(46):3675-7.
2
Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.用于Xp11.2易位性肾细胞癌和肺泡软组织肉瘤的TFE3断裂分离荧光原位杂交检测法的验证与应用
Diagn Pathol. 2015 Sep 29;10:179. doi: 10.1186/s13000-015-0412-z.
3
TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.TFE3 断裂分离 FISH 检测与 TFE3 或组织蛋白酶 K 免疫组化染色单独检测相比,对 Xp11.2 易位相关性肾细胞癌具有更高的敏感性:扩大形态学谱。
Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.
4
Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.用于Xp11.2易位性肾细胞癌的TFE3分离FISH检测法的验证
Diagn Mol Pathol. 2011 Sep;20(3):129-37. doi: 10.1097/PDM.0b013e31820e9c67.
5
Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.新设计的断裂分离和ASPL-TFE3双融合荧光原位杂交检测法在诊断Xp11.2易位性肾细胞癌和ASPL-TFE3肾细胞癌中具有应用价值:一篇遵循STARD规范的文章
Medicine (Baltimore). 2015 May;94(19):e873. doi: 10.1097/MD.0000000000000873.
6
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.在肾脏肿瘤咨询服务中使用 TFE3 断裂 FISH 检测。
Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.
7
Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma.Xp11.2 易位性肾细胞癌中分离式荧光原位杂交检测的应用价值。
Virchows Arch. 2011 Sep;459(3):299-306. doi: 10.1007/s00428-011-1127-5. Epub 2011 Jul 20.
8
RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.RBM10-TFE3肾细胞癌:由于隐匿性染色体Xp11.2倒位导致TFE3荧光原位杂交假阴性,可能成为诊断陷阱。
Am J Surg Pathol. 2017 May;41(5):655-662. doi: 10.1097/PAS.0000000000000835.
9
TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.TMED6-COG8是TFE3易位性肾细胞癌的一种新型分子标志物。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2690-9. eCollection 2015.
10
Fluorescence in situ hybridization analysis on cytologic smears: An accurate and efficient method in the diagnosis of melanotic Xp11 translocation renal cancer.细胞学涂片的荧光原位杂交分析:一种诊断黑素性Xp11易位性肾癌的准确且高效的方法。
Diagn Cytopathol. 2018 Sep;46(9):786-789. doi: 10.1002/dc.23961. Epub 2018 May 3.

引用本文的文献

1
Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?肿瘤相关的微血管生成和淋巴管生成是否可作为 Xp11.2 易位性肾细胞癌患者的新型预后因素?
BMC Cancer. 2020 Dec 2;20(1):1182. doi: 10.1186/s12885-020-07696-2.
2
Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: a Retrospective Multicentre Study in China.中国多中心回顾性研究:儿童与成人 Xp11 易位性肾细胞癌的临床病理特征与结局比较。
Sci Rep. 2020 Feb 10;10(1):2249. doi: 10.1038/s41598-020-59162-5.
3
Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.
与Xp11.2易位/TFE3基因融合相关的肾细胞癌:临床特征、治疗与预后
PLoS One. 2016 Nov 28;11(11):e0166897. doi: 10.1371/journal.pone.0166897. eCollection 2016.